The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Exact Sciences Corporation(NASDAQ:EXAS) 
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also pr...
Website: http://www.exactsciences.com
Founded: 1995
Full Time Employees: 6,400 (Dec 2022)
CEO: Kevin Conroy
Sector: Healthcare
Industry: Diagnostics & Research
Exact Sciences Number of employees (headcount)
Exact Sciences Days Payable Outstanding ttm (DPO)
Exact Sciences Days Receivable Outstanding ttm (DSO)
Exact Sciences Days Inventory Outstanding ttm (DIO)
Exact Sciences Op Cashflow Per Share ttm
Exact Sciences Free Cashflow Per Share ttm
Exact Sciences Cash Per Share ttm
Exact Sciences P/S ratio ttm
Exact Sciences (GAAP) P/E ratio ttm
Exact Sciences P/B ratio ttm
No extra charts and metrics for this ticker.